Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis by Hartung, H-P, Berger, T, Bermel, RA, Brochet, B, Carroll, WM, Holmøy, T, Karabudak, R, Killestein, J, Nos, C, Patti, F, Ross, A Perrin, Vanopdenbosch, L, Vollmer, T, Buffels, R, Garas, M, Kadner, K, Manfrini, M, Wang, Q, Freedman, MS

Get full text

Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study by Sundar, S., Jha, T. K., Thakur, C. P., Mishra, M., Singh, V. P., Buffels, R.

Get full text

Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers by DROSTE, J. A. H, VERWEIJ-VAN WISSEN, C. P. W. G. M, KEARNEY, B. P, BUFFELS, R, VANHORSSEN, P. J, HEKSTER, Y. A, BURGER, D. M

Get full text

P34 Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies by Van Wijmeersch, B., Buffels, R., Clinch, S., Eggebrecht, J., Kuhelj, R., Wei, W., Vermersch, P.

Get full text

Pregnancy outcomes in patients treated with ocrelizumab by Oreja-Guevara, C., Wray, S., Buffels, R., Zecevic, D., Vukusic, S.

Get full text

Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study by FASSAS, A, BUFFELS, R, ANAGNOSTOPOULOS, A, GACOS, E, VADIKOLIA, C, HALOUDIS, P, KALOYANNIDIS, P

Get full text

Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim result... by Vermersch, P., Eralinna, J.P., Nicholas, R., Oreja-Guevara, C., Siva, A., Van Wijmeersch, B., Wiendl, H., Buffels, R., Kuhelj, R., Wei, W., Comi, G.

Get full text

Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I–II study by Fassas, A., Buffels, R., Anagnostopoulos, A., Gacos, E., Vadikolia, C., Haloudis, P., Kaloyannidis, P.

Get full text

Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib... by Yamout, B., Brochet, B., Nos, C., Freedman, M.S., Killstein, J., Overell, J., Buffels, R., Fitovski, K., Mehta, L., Wang, Q., Hartung, H.

Get full text

Shorter infusion time of ocrelizumab: Results from the randomized, doubleblind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis by Hartung, HP, Berger, T, Bermel, RA, Brochet, B, Carroll, WM, Holmøy, Trygve, Karabudak, R, Killestein, J, Nos, C, Patti, Francesco, Ross, A, Vanopdenbosch, L, Vollmer, Timothy, Buffels, R, Garas, M, Kadner, Kathrin, Manfrini, M, Wang, Q, Freedman, M

Get full text

Safety of high‐dose liposomal daunorubicin (daunoxome) for refractory or relapsed acute myeloblastic leukaemia by Fassas, Athanasios, Buffels, Regine, Kaloyannidis, Panayotis, Anagnostopoulos, Achilles

Get full text

Assessment of progression of COPD: report of a workshop held in Leuven, 11–12 March 2004 by Decramer, M, Gosselink, R, Rutten-Van Mölken, M, Buffels, J, Van Schayck, O, Gevenois, P-A, Pellegrino, R, Derom, E, De Backer, W

Get full text